Rafferty Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-174,571
| Closed | -$1.44M | – | 1325 |
|
|
2021
Q2 | $1.44M | Buy |
174,571
+47,229
| +37% | +$389K | 0.01% | 775 |
|
|
2021
Q1 | $1.14M | Buy |
127,342
+102,941
| +422% | +$922K | 0.01% | 743 |
|
|
2020
Q4 | $282K | Sell |
24,401
-40,367
| -62% | -$467K | ﹤0.01% | 842 |
|
|
2020
Q3 | $674K | Buy |
64,768
+34,851
| +116% | +$363K | 0.01% | 638 |
|
|
2020
Q2 | $393K | Buy |
+29,917
| New | +$393K | 0.01% | 766 |
|
|
2020
Q1 | – | Sell |
-51,279
| Closed | -$1.06M | – | 864 |
|
|
2019
Q4 | $1.06M | Sell |
51,279
-28,230
| -36% | -$584K | 0.02% | 539 |
|
|
2019
Q3 | $1.09M | Sell |
79,509
-17,275
| -18% | -$237K | 0.02% | 516 |
|
|
2019
Q2 | $1.19M | Buy |
96,784
+1,972
| +2% | +$24.2K | 0.02% | 524 |
|
|
2019
Q1 | $1.18M | Buy |
+94,812
| New | +$1.18M | 0.02% | 517 |
|